Peer-Reviewed Publication
Thorac Cancer2026;17(18):e70354.September 1, 2026Journal Article

Artificial Intelligence-Assisted Pulmonary Nodule Diagnosis by Thoracic Surgeons: A Comparative Study on Clinical Effectiveness.

Yeong Jeong Jeon1, Jonghun Jeong2,3, Doohyun Park2, Jung-Hyun Kang2, Eun Kyoung Hong4, Younjoon Chung5, Boram Park6, Seong Yong Park1
1Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
2Vuno Inc., Seoul, Republic of Korea.
3Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
4Department of Radiology, Brigham & Women's Hospital, Boston, Massachusetts, USA.
5Department of Computer Science, Yale School of Engineering and Applied Science, Yale University, New Haven, Connecticut, USA.
6College of Medicine, Inha University, Incheon, Republic of Korea.

Abstract

MAIN PROBLEM: Clinician experience variability affects lung cancer detection using computed tomography. AI-based computer-aided diagnosis (CAD) systems can improve diagnostic accuracy, but their influence on thoracic surgeons with varying experience is unclear. This study aimed to evaluate the impact of CAD system on thoracic surgeons' assessment of pulmonary nodule malignancy. METHODS: A multire…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.